One of these comprises evaluation of the potential of a new therapy to inhibit drug-metabolizing enzymes, which can impact clearance of concomitantly administered drugs. It is key that these studies include high-quality resources and are conducted with scientific rigor.

Join industry experts for this insightful webinar to learn more about enzyme inhibition studies. We’ll explore: 

• How these studies drive informed decisions for drug developers
• Frequently asked questions from sponsors
• Recommendations for achieving successful regulatory submission 
• Critical design considerations, from determination of supporting data to conclusive interpretation
• And more